Global Alzheimer's Disease Market and Competitive Landscape – 2017
The latest research from Fore Pharma, Global Alzheimer's Disease Market and Competitive Landscape – 2017, provides comprehensive insights into Alzheimer's Disease pipeline, epidemiology, market valuations, product sales, market forecast, product forecasts, and market shares. This study accurately estimates and forecast Alzheimer's Disease market size and drug sales. This research also provides insights into Alzheimer's Disease epidemiology and late stage pipeline.
The report is classified into twelve sections – Alzheimer's Disease overview with definitions, symptoms, etiology, diagnosis, treatment options; Alzheimer's Disease pipeline insights covering late stage clinical trials pipeline; Alzheimer's Disease prevalence trends by countries; Alzheimer's Disease market size and forecast by countries, market events, trends; product sales and forecast by countries; market shares by countries. The research scope includes G7 countries – US, Germany, France, Italy, Spain, UK, Japan, Europe, Global.
Research Scope:
- Alzheimer's Disease pipeline: Find out the drugs in clinical trials for Alzheimer's Disease by stages, phase 3 clinical trials, phase 2 clinical trials, and phase 1 clinical trials, by pharmacological class, by company
- Alzheimer's Disease epidemiology: Find out the prevalence of Alzheimer's Disease by countries – US, Europe, Germany, France, Italy, Spain, UK, Japan; prevalence forecast to 2025
- Alzheimer's Disease products: Identify key products marketed and prescribed for Alzheimer's Disease by brand name, by molecule, by company, by branded / generic, by countries – US, Europe, Germany, France, Italy, Spain, UK, Japan
- Alzheimer's Disease market size: Find out the market size for Alzheimer's Disease drugs by countries – US, Europe, Germany, France, Italy, Spain, UK, Japan; Find out how the market advanced from 2012
- Alzheimer's Disease drug sales: Find out the sales of Alzheimer's Disease drugs by countries – US, Europe, Germany, France, Italy, Spain, UK, Japan, Global
- Alzheimer's Disease drugs sales forecast: Sales forecast for Alzheimer's Disease drugs to 2021 by countries – US, Europe, Germany, France, Italy, Spain, UK, Japan
- Alzheimer's Disease market share analysis: Find out the market shares of Alzheimer's Disease drugs and outlook by countries – US, Europe, Germany, France, Italy, Spain, UK, Japan
- Evaluate commercial market opportunities for Alzheimer's Disease drugs
- Synthesize insights for business development & licensing
- Track market size, competitor drug sales, market shares in Alzheimer's Disease market
- Develop in-depth knowledge of competition and markets
- Analyze sales data to update your brand planning trackers
- Develop tactics and strategies to take advantage of opportunities in the market
- Track market trends and analyze key events in Alzheimer's Disease market
- Develop forecast models, healthcare frameworks, or economic models
- Answer key business questions; supports decision making in R&D to long term marketing strategies
- 1. Alzheimer's Disease: Disease Overview
- 1.1. Alzheimer's Disease Symptoms
- 1.2. Alzheimer's Disease Etiology
- 1.3. Alzheimer's Disease Diagnosis
- 1.4. Alzheimer's Disease Treatment Options
- 2. Alzheimer's Disease Pipeline Insights
- 2.1. Alzheimer's Disease Phase 3 Clinical Trials
- 2.2. Alzheimer's Disease Phase 2 Clinical Trials
- 2.3. Alzheimer's Disease Phase 1 Clinical Trials
- 3. Alzheimer's Disease Epidemiology Analysis
- 4. US Alzheimer's Disease Market Insights
- 4.1. Marketed Products for Alzheimer's Disease in US
- 4.2. US Alzheimer's Disease Market Size & Forecast
- 4.3. US Alzheimer's Disease Product Sales Forecast
- 4.4. US Alzheimer's Disease Market Share Analysis
- 5. Germany Alzheimer's Disease Market Insights
- 5.1. Marketed Products for Alzheimer's Disease in Germany
- 5.2. Germany Alzheimer's Disease Market Size & Forecast
- 5.3. Germany Alzheimer's Disease Product Sales Forecast
- 5.4. Germany Alzheimer's Disease Market Share Analysis
- 6. France Alzheimer's Disease Market Insights
- 6.1. Marketed Products for Alzheimer's Disease in France
- 6.2. France Alzheimer's Disease Market Size & Forecast
- 6.3. France Alzheimer's Disease Product Sales Forecast
- 6.4. France Alzheimer's Disease Market Share Analysis
- 7. Italy Alzheimer's Disease Market Insights
- 7.1. Marketed Products for Alzheimer's Disease in Italy
- 7.2. Italy Alzheimer's Disease Market Size & Forecast
- 7.3. Italy Alzheimer's Disease Product Sales Forecast
- 7.4. Italy Alzheimer's Disease Market Share Analysis
- 8. Spain Alzheimer's Disease Market Insights
- 8.1. Marketed Products for Alzheimer's Disease in Spain
- 8.2. Spain Alzheimer's Disease Market Size & Forecast
- 8.3. Spain Alzheimer's Disease Product Sales Forecast
- 8.4. Spain Alzheimer's Disease Market Share Analysis
- 9. UK Alzheimer's Disease Market Insights
- 9.1. Marketed Products for Alzheimer's Disease in UK
- 9.2. UK Alzheimer's Disease Market Size & Forecast
- 9.3. UK Alzheimer's Disease Product Sales Forecast
- 9.4. UK Alzheimer's Disease Market Share Analysis
- 10. Europe Alzheimer's Disease Market Insights
- 10.1. Europe Alzheimer's Disease Market Size & Forecast
- 10.2. Europe Alzheimer's Disease Product Sales Forecast
- 10.3. Europe Alzheimer's Disease Market Share Analysis
- 11. Japan Alzheimer's Disease Market Insights
- 11.1. Marketed Products for Alzheimer's Disease in Japan
- 11.2. Japan Alzheimer's Disease Market Size & Forecast
- 11.3. Japan Alzheimer's Disease Product Sales Forecast
- 11.4. Japan Alzheimer's Disease Market Share Analysis
- 12. Global Alzheimer's Disease Market Insights
- 12.1. Global Alzheimer's Disease Market Size & Forecast
- 12.2. Global Alzheimer's Disease Product Sales Forecast
- 12.3. Global Alzheimer's Disease Market Share Analysis
- 13. Research Methodology
- LIST OF TABLES
- Table 1: Alzheimer's Disease Phase 3 Clinical Trials, Global, 2017
- Table 2: Alzheimer's Disease Phase 2 Clinical Trials, Global, 2017
- Table 3: Alzheimer's Disease Phase 1 Clinical Trials, Global, 2017
- Table 4: Alzheimer's Disease Prevalence by G7 Countries, 2012 - 2021
- Table 5: Marketed Products for Alzheimer's Disease in US, 2017
- Table 6: US Alzheimer's Disease Market Size & Forecast ($mn), 2012 - 2021
- Table 7: US Alzheimer's Disease Product Sales ($mn), 2012 - 2021
- Table 8: US Alzheimer's Disease Market Trends, 2012 - 2021
- Table 9: Marketed Products for Alzheimer's Disease in Germany, 2017
- Table 10: Germany Alzheimer's Disease Market Size & Forecast ($mn), 2012 - 2021
- Table 11: Germany Alzheimer's Disease Product Sales ($mn), 2012 - 2021
- Table 12: Germany Alzheimer's Disease Market Trends, 2012 - 2021
- Table 13: Marketed Products for Alzheimer's Disease in France, 2017
- Table 14: France Alzheimer's Disease Market Size & Forecast ($mn), 2012 - 2021
- Table 15: France Alzheimer's Disease Product Sales ($mn), 2012 - 2021
- Table 16: France Alzheimer's Disease Market Trends, 2012 - 2021
- Table 17: Marketed Products for Alzheimer's Disease in Italy, 2017
- Table 18: Italy Alzheimer's Disease Market Size & Forecast ($mn), 2012 - 2021
- Table 19: Italy Alzheimer's Disease Product Sales ($mn), 2012 - 2021
- Table 20: Italy Alzheimer's Disease Market Trends, 2012 - 2021
- Table 21: Marketed Products for Alzheimer's Disease in Spain, 2017
- Table 22: Spain Alzheimer's Disease Market Size & Forecast ($mn), 2012 - 2021
- Table 23: Spain Alzheimer's Disease Product Sales ($mn), 2012 - 2021
- Table 24: Spain Alzheimer's Disease Market Trends, 2012 - 2021
- Table 25: Marketed Products for Alzheimer's Disease in UK, 2017
- Table 26: UK Alzheimer's Disease Market Size & Forecast ($mn), 2012 - 2021
- Table 27: UK Alzheimer's Disease Product Sales ($mn), 2012 - 2021
- Table 28: UK Alzheimer's Disease Market Trends, 2012 - 2021
- Table 29: Europe Alzheimer's Disease Market Size & Forecast ($mn), 2012 - 2021
- Table 30: Europe Alzheimer's Disease Product Sales ($mn), 2012 - 2021
- Table 31: Marketed Products for Alzheimer's Disease in Japan, 2017
- Table 32: Japan Alzheimer's Disease Market Size & Forecast ($mn), 2012 - 2021
- Table 33: Japan Alzheimer's Disease Product Sales ($mn), 2012 - 2021
- Table 34: Japan Alzheimer's Disease Market Trends, 2012 - 2021
- Table 35: Global Alzheimer's Disease Market Size & Forecast ($mn), 2012 - 2021
- Table 36: Global Alzheimer's Disease Product Sales ($mn), 2012 - 2021
- LIST OF FIGURES
- Figure 1: Alzheimer's Disease Pipeline by Phase (%), Global, 2017
- Figure 2: Alzheimer's Disease Prevalence by G7 Countries, 2012 - 2021
- Figure 3: US Alzheimer's Disease Market Size ($mn), 2012 - 2021
- Figure 4: US Alzheimer's Disease Product Sales ($mn), 2012 - 2021
- Figure 5: US Alzheimer's Disease Market Share by Products (%), 2016
- Figure 6: US Alzheimer's Disease Market - Future Market Share (%), 2021
- Figure 7: Germany Alzheimer's Disease Market Size ($mn), 2012 - 2021
- Figure 8: Germany Alzheimer's Disease Product Sales ($mn), 2012 - 2021
- Figure 9: Germany Alzheimer's Disease Market Share by Products (%), 2016
- Figure 10: Germany Alzheimer's Disease Market - Future Market Share (%), 2021
- Figure 11: France Alzheimer's Disease Market Size ($mn), 2012 - 2021
- Figure 12: France Alzheimer's Disease Product Sales ($mn), 2012 - 2021
- Figure 13: France Alzheimer's Disease Market Share by Products (%), 2016
- Figure 14: France Alzheimer's Disease Market - Future Market Share (%), 2021
- Figure 15: Italy Alzheimer's Disease Market Size ($mn), 2012 - 2021
- Figure 16: Italy Alzheimer's Disease Product Sales ($mn), 2012 - 2021
- Figure 17: Italy Alzheimer's Disease Market Share by Products (%), 2016
- Figure 18: Italy Alzheimer's Disease Market - Future Market Share (%), 2021
- Figure 19: Spain Alzheimer's Disease Market Size ($mn), 2012 - 2021
- Figure 20: Spain Alzheimer's Disease Product Sales ($mn), 2012 - 2021
- Figure 21: Spain Alzheimer's Disease Market Share by Products (%), 2016
- Figure 22: Spain Alzheimer's Disease Market - Future Market Share (%), 2021
- Figure 23: UK Alzheimer's Disease Market Size ($mn), 2012 - 2021
- Figure 24: UK Alzheimer's Disease Product Sales ($mn), 2012 - 2021
- Figure 25: UK Alzheimer's Disease Market Share by Products (%), 2016
- Figure 26: UK Alzheimer's Disease Market - Future Market Share (%), 2021
- Figure 27: Europe Alzheimer's Disease Market Size ($mn), 2012 - 2021
- Figure 28: Europe Alzheimer's Disease Product Sales ($mn), 2012 - 2021
- Figure 29: Europe Alzheimer's Disease Market Share by Products (%), 2016
- Figure 30: Europe Alzheimer's Disease Market - Future Market Share (%), 2021
- Figure 31: Japan Alzheimer's Disease Market Size ($mn), 2012 - 2021
- Figure 32: Japan Alzheimer's Disease Product Sales ($mn), 2012 - 2021
- Figure 33: Japan Alzheimer's Disease Market Share by Products (%), 2016
- Figure 34: Japan Alzheimer's Disease Market - Future Market Share (%), 2021
- Figure 35: Global Alzheimer's Disease Market Size ($mn), 2012 - 2021
- Figure 36: Global Alzheimer's Disease Product Sales ($mn), 2012 - 2021
- Figure 37: Global Alzheimer's Disease Market Share by Products (%), 2016
- Figure 38: Global Alzheimer's Disease Market - Future Market Share (%), 2021
Research Assistance
Download our eBook: How to Succeed Using Market Research
Learn how to effectively navigate the market research process to help guide your organization on the journey to success.
Download eBook